IVCC receives new grant funding to support the development of innovative vector control tools for malaria

IVCC is pleased to confirm that it is the recipient of a new grant from the Bill & Melinda Gates Foundation.  This new grant of $85 million over 5 years is the largest ever investment in IVCC by the foundation.  With this key funding milestone, alongside support from other funding partners, IVCC will be able to sustain and create new partnerships to continue to deliver an ambitious pipeline of innovative vector control products in line with its renewed strategy.

Through the continuous support of its funding partners, like the foundation, and in partnerships with industry, IVCC has supported the delivery of a suite of innovative vector control tools, including next generation indoor residual sprays and dual-active ingredient bed nets which have proven to be the cornerstone of malaria eradication efforts since the turn of the century.

For the effectiveness of these tools to be maintained over the long term, additional modes of action need to become available so that the challenge of insecticide resistance can be better managed, and the longevity of these products maximised.  This funding will also support IVCC’s strategy to further expand the vector control toolbox; identifying, developing and bringing to market alternative tools to address other technical gaps in mosquito borne disease transmission.

Protecting these new tools against the threat of resistance and expanding the vector control toolbox will provide national malaria control programmes with a choice of effective vector control options to further advance the elimination of malaria in their respective countries.

Justin McBeath, CEO of IVCC said: “I would like to thank the Bill & Melinda Gates Foundation for the trust placed in IVCC to deliver on our strategic goals and in recognising our new strategic focus. It reflects a shared vision of the critical need for innovation in vector control to address the spread of insecticide resistance and an expanded toolbox of interventions.  With this support, we are optimistic that urgently needed new modes of action can be developed and delivered to improve and save the lives of those affected by malaria.”

For further information, please contact:

Chris Larkin, Director of Communications and Operations, IVCC
Email: Christopher.larkin@ivcc.com
Tel: 07712 402498